Glaukos (GKOS) Share-based Compensation (2014 - 2026)
Glaukos (GKOS) posted quarterly Share-based Compensation of $122.1 million for Q2 2026, up 577.62% year-over-year from $18.0 million in Q2 2025, and up 659.71% quarter-over-quarter from $16.1 million in Q1 2026.
Glaukos (GKOS) Share-based Compensation (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has reported Share-based Compensation for 13 consecutive years, with $122.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Share-based Compensation rose 577.62% year-over-year to $122.1 million; the TTM figure through Jun 2026 stood at $122.1 million (up 124.06% YoY), while the FY2025 annual figure was $72.0 million, up 9.59% from the prior year.
- Share-based Compensation climbed to $122.1 million in Q2 2026 per GKOS's latest filing, from $16.1 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $122.1 million in Q2 2026 and bottomed at -$702000.0 in Q2 2023.
- Historically, Share-based Compensation has averaged $20.6 million across 5 years, with a median of $12.3 million in 2022.
- Annual changes were most pronounced in 2023 — Share-based Compensation sank 394.96% — and 2024, when it jumped 1356.27%.
- Glaukos' Share-based Compensation stood at $11.7 million in 2022, then rose by 11.11% to $13.0 million in 2023, then surged by 52.9% to $19.9 million in 2024, then retreated by 12.88% to $17.3 million in 2025, then soared by 605.78% to $122.1 million in 2026.
- Business Quant data shows GKOS's Share-based Compensation at $122.1 million in Q2 2026, $16.1 million in Q1 2026, and $17.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Glaukos | 10.91 Bn | 10.80 Bn | 151.59 Mn | 122.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 122.10 Mn |
| Jun 30, 2026 | 122.10 Mn |
| Mar 31, 2026 | 16.07 Mn |
| Mar 31, 2026 | 16.07 Mn |
| Dec 31, 2025 | 17.30 Mn |
| Dec 31, 2025 | 17.30 Mn |
| Sep 30, 2025 | 92.30 Mn |
| Sep 30, 2025 | 92.30 Mn |
| Jun 30, 2025 | 18.02 Mn |
| Jun 30, 2025 | 18.02 Mn |
| Mar 31, 2025 | 2.20 Mn |
| Mar 31, 2025 | 2.20 Mn |
| Dec 31, 2024 | 19.86 Mn |
| Dec 31, 2024 | 19.86 Mn |
| Sep 30, 2024 | 14.42 Mn |
| Sep 30, 2024 | 14.42 Mn |
| Jun 30, 2024 | 8.82 Mn |
| Jun 30, 2024 | 8.82 Mn |
| Mar 31, 2024 | 13.37 Mn |
| Mar 31, 2024 | 13.37 Mn |